↓ Skip to main content

Clinical and molecular characterization of 40 patients with classic Ehlers–Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
8 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
59 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical and molecular characterization of 40 patients with classic Ehlers–Danlos syndrome: identification of 18 COL5A1 and 2 COL5A2 novel mutations
Published in
Orphanet Journal of Rare Diseases, January 2013
DOI 10.1186/1750-1172-8-58
Pubmed ID
Authors

Marco Ritelli, Chiara Dordoni, Marina Venturini, Nicola Chiarelli, Stefano Quinzani, Michele Traversa, Nicoletta Zoppi, Annalisa Vascellaro, Anita Wischmeijer, Emanuela Manfredini, Livia Garavelli, Piergiacomo Calzavara-Pinton, Marina Colombi

Abstract

Classic Ehlers-Danlos syndrome (cEDS) is a rare autosomal dominant connective tissue disorder that is primarily characterized by skin hyperextensibility, abnormal wound healing/atrophic scars, and joint hypermobility. A recent study demonstrated that more than 90% of patients who satisfy all of these major criteria harbor a type V collagen (COLLV) defect.

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Italy 1 2%
Unknown 57 97%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 11 19%
Other 10 17%
Researcher 7 12%
Student > Bachelor 6 10%
Professor 4 7%
Other 14 24%
Unknown 7 12%
Readers by discipline Count As %
Medicine and Dentistry 23 39%
Agricultural and Biological Sciences 15 25%
Biochemistry, Genetics and Molecular Biology 11 19%
Nursing and Health Professions 1 2%
Veterinary Science and Veterinary Medicine 1 2%
Other 1 2%
Unknown 7 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2020.
All research outputs
#2,695,438
of 14,574,990 outputs
Outputs from Orphanet Journal of Rare Diseases
#336
of 1,597 outputs
Outputs of similar age
#28,230
of 150,578 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#5
of 36 outputs
Altmetric has tracked 14,574,990 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,597 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 150,578 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.